INTEGRATED BIOPHARMA INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Integrated Biopharma Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2018 to Q1 2024.
  • Integrated Biopharma Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $2.02M, a 28.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.02M -$819K -28.8% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $2.25M -$806K -26.4% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $2.47M -$174K -6.58% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.62M +$756K +40.5% Jun 30, 2023 10-Q 2024-05-10
Q1 2023 $2.84M +$848K +42.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.05M +$938K +44.4% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 $2.65M +$407K +18.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.87M -$498K -21.1% Jun 30, 2022 10-K 2023-09-15
Q1 2022 $1.99M -$469K -19.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.12M -$468K -18.1% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $2.24M -$465K -17.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $2.37M -$459K -16.3% Jun 30, 2021 10-K 2022-09-13
Q1 2021 $2.46M -$483K -16.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.58M -$469K -15.4% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 $2.7M -$465K -14.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $2.82M -$460K -14% Jun 30, 2020 10-K 2021-09-02
Q1 2020 $2.94M -$456K -13.4% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $3.05M -$461K -13.1% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 $3.17M -$457K -12.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $3.28M Jun 30, 2019 10-K 2020-09-23
Q1 2019 $3.4M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $3.51M Dec 31, 2018 10-Q 2019-02-13
Q3 2018 $3.63M Sep 30, 2018 10-Q 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.